Abstract

Dysregulation of the immune system can initiate chronic inflammatory responses that exacerbate disease pathology. Multipotent adult progenitor cells (MAPC cells), an adult adherent bone-marrow derived stromal cell, have been observed to promote the resolution of uncontrolled inflammatory responses in a variety of clinical conditions including acute ischemic stroke, acute myocardial infarction (AMI), graft vs host disease (GvHD), and acute respiratory distress syndrome (ARDS). One of the proposed mechanisms by which MAPC cells modulate immune responses is via the induction of regulatory T cells (Tregs), however, the mechanism(s) involved remains to be fully elucidated. Herein, we demonstrate that, in an in vitro setting, MAPC cells increase Treg frequencies by promoting Treg proliferation and CD4+ T cell differentiation into Tregs. Moreover, MAPC cell-induced Tregs (miTregs) have a more suppressive phenotype characterized by increased expression of CTLA-4, HLA-DR, and PD-L1 and T cell suppression capacity. MAPC cells also promoted Treg activation by inducing CD45RA+ CD45RO+ transitional Tregs. Additionally, we identify transforming growth factor beta (TGFβ) as an essential factor for Treg induction secreted by MAPC cells. Furthermore, inhibition of indoleamine 2, 3-dioxygenase (IDO) resulted in decreased Treg induction by MAPC cells demonstrating IDO involvement. Our studies also show that CD14+ monocytes play a critical role in Treg induction by MAPC cells. Our study describes MAPC cell dependent Treg phenotypic changes and provides evidence of potential mechanisms by which MAPC cells promote Treg differentiation.

Highlights

  • Abbreviations MAPC cells Multipotent adult progenitor cells acute myocardial infarction (AMI) Acute myocardial infarction graft vs host disease (GvHD) Graft versus host disease acute respiratory distress syndrome (ARDS) Acute respiratory distress syndrome Tregs Regulatory T cells peripheral blood mononuclear cells (PBMCs) Peripheral blood mononuclear cells MAPC cell induced Tregs (miTreg) MAPC cell-induced Tregs TGFβ Transforming growth factor beta IDO Indoleamine 2,3 dioxygenase cytotoxic T lymphocyte associated protein 4 (CTLA-4) Cytotoxic T lymphocyte associated protein 4 PD-L1 Programmed death ligand 1 HLA-DR Human leukocyte antigen DR isotype natural Tregs (nTregs) Natural Tregs

  • Tregs are characterized as natural Tregs, which are developed in the thymus during embryonic state, or induced Tregs that arise from effector T cells in the periphery, preferentially during inflammatory c­ onditions[1]

  • Since T cell activation can result in transient expression of FoxP3 and CD25 on effector T cells, making the identification of Tregs more challenging, our studies were performed in the absence of Scientific Reports | (2021) 11:13549 |

Read more

Summary

Introduction

Abbreviations MAPC cells Multipotent adult progenitor cells AMI Acute myocardial infarction GvHD Graft versus host disease ARDS Acute respiratory distress syndrome Tregs Regulatory T cells PBMCs Peripheral blood mononuclear cells miTregs MAPC cell-induced Tregs TGFβ Transforming growth factor beta IDO Indoleamine 2,3 dioxygenase CTLA-4 Cytotoxic T lymphocyte associated protein 4 PD-L1 Programmed death ligand 1 HLA-DR Human leukocyte antigen DR isotype nTregs Natural Tregs. Tregs are characterized as natural Tregs (nTregs), which are developed in the thymus during embryonic state, or induced Tregs (iTregs) that arise from effector T cells in the periphery, preferentially during inflammatory c­ onditions[1] Tregs express both CD4 and CD25 surface antigens as well as the transcription factor, FoxP3, a critical gene involved in Treg development and ­function[2,3]. In the case of ischemic stroke, a Phase 2 clinical trial revealed that MultiStem treatment improved clinical outcomes and reduced inflammation characterized by decreasing T effector cells and pro-inflammatory cytokines levels in the b­ lood[25]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call